Cadrenal Therapeutics, Inc. — SCHEDULE 13G/A Filings
2 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Cadrenal Therapeutics, Inc. (CVKD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Cadrenal Therapeutics, Inc. has filed 2 SCHEDULE 13G/A documents with the SEC since 2022. To view all SEC filings by Cadrenal Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001213900-25-012684 | Feb 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-003853 | Jan 15, 2025 | — |